Company Directory / research
PrivateFor profitresearchAmsterdam, Netherlands
VectorY
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
- Founded
- 2020 6 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $160M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
6 years old.
Reach
Website ranked #4,054,714 in the world for traffic, about 3k visits a month.
What it does
Biotechnology
Funding, as listed
$160M currency not stated
- Rounds2
- LatestSeries a, Nov 2023
- Investors8, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about VectorY, field by field. Contact details are held but never shown.
The company
- Name
- VectorY
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- Anthony Newcombe, Barbara Sanders, Pavlina Konstantinova, Sander van Deventer
- Industry
- research
- Categories
- Biotechnology
Where
- City
- Amsterdam
- Country
- Netherlands
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #4,054,714
- Monthly web visits
- 2,606
- Apps
- 5
Funding, as listed
- Total
- 160,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Nov 2023
- Investors
- 8
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
VectorY may be growing as it has successfully raised millions to advance its ALS therapy targeting TDP-43, which is a significant financial milestone indicating investor confidence and the potential for increased research and development activities. This funding is a crucial growth indicator as it enables the company to further its therapeutic development, which is central to its operations in the biotechnology industry. Additionally, the fact that this fundraising event is noteworthy enough to be reported suggests that VectorY is making substantial progress within its sector.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Netherlands.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 174,966 companies in Netherlands and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.